- Home
- FTHM vs XCUR Comparison
FTHM vs XCUR Comparison
Compare FTHM & XCUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- XCUR
- Stock Information
- Founded
- FTHM 2010
- XCUR 2011
- Country
- FTHM United States
- XCUR United States
- Employees
- FTHM N/A
- XCUR N/A
- Industry
- FTHM Real Estate
- XCUR Biotechnology: Pharmaceutical Preparations
- Sector
- FTHM Finance
- XCUR Health Care
- Exchange
- FTHM Nasdaq
- XCUR Nasdaq
- Market Cap
- FTHM 38.3M
- XCUR 46.0M
- IPO Year
- FTHM 2020
- XCUR N/A
- Fundamental
- Price
- FTHM $1.30
- XCUR $7.15
- Analyst Decision
- FTHM Buy
- XCUR
- Analyst Count
- FTHM 1
- XCUR 0
- Target Price
- FTHM $2.50
- XCUR N/A
- AVG Volume (30 Days)
- FTHM 150.0K
- XCUR 86.5K
- Earning Date
- FTHM 08-12-2025
- XCUR 08-08-2025
- Dividend Yield
- FTHM N/A
- XCUR N/A
- EPS Growth
- FTHM N/A
- XCUR N/A
- EPS
- FTHM N/A
- XCUR N/A
- Revenue
- FTHM $390,032,000.00
- XCUR N/A
- Revenue This Year
- FTHM $32.40
- XCUR N/A
- Revenue Next Year
- FTHM $18.04
- XCUR N/A
- P/E Ratio
- FTHM N/A
- XCUR N/A
- Revenue Growth
- FTHM 19.16
- XCUR N/A
- 52 Week Low
- FTHM $0.65
- XCUR $1.44
- 52 Week High
- FTHM $3.37
- XCUR $36.00
- Technical
- Relative Strength Index (RSI)
- FTHM 50.06
- XCUR 48.71
- Support Level
- FTHM $1.05
- XCUR $7.00
- Resistance Level
- FTHM $1.50
- XCUR $7.92
- Average True Range (ATR)
- FTHM 0.14
- XCUR 0.70
- MACD
- FTHM 0.00
- XCUR 0.03
- Stochastic Oscillator
- FTHM 35.71
- XCUR 52.97
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About XCUR Exicure Inc.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.